enGene Holdings Inc.ENGNNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+82.5%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+82.5%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
6.1x
Strong expansion
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 146.59% |
| 2024 | 132.80% |
| 2023 | 6.41% |
| 2022 | 24.11% |
| 2021 | 17.41% |
| 2020 | 0.00% |